Fruquintinib

Fruquintinib


Fruquintinib (HMPL-013) is a potent and selective VEGFR1/2/3 inhibitor (IC50s = 33, 0.35, and 35 nM, respectively). It also inhibits RET, FGFR1, and c-Kit at higher concentrations. Fruquintinib suppresses VEGF-induced endothelial cell proliferation and tube formation and reduces tumor growth in multiple xenograft models. Reagent grade, for research use only.

Molecular structure of the compound BP-43650
    • Unit
    • Price
    • Qty
    • 100 MG
    • $180.00
    • 250 MG
    • $320.00
    • 500 MG
    • $480.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire